Completed PHASE4 INTERVENTIONAL 2-arm NCT01392014

Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases (DHP+PQ)

Effectiveness of Dihydroartemisinin-piperaquine With or Without Primaquine on Gametocytes Plasmodium Falciparum in Mesoendemic Area of Indonesia

Sponsor: Indonesia University

Conditions Malaria

Interventions dihydroartemisinin-piperaquine dihydroartemisinin-piperaquine + primaquine

Updated 6 times since 2017 Last updated: Jul 8, 2011 Started: Dec 31, 2008 Primary completion: Mar 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01392014, this PHASE4 trial focuses on Malaria and remains completed. Sponsored by Indonesia University, it has been updated 6 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indonesia University

Data source: Indonesia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lampung, Indonesia